| 5168 |
Centers for Disease Control and Prevention |
Html |
en |
New York Activities to Prevent HAIs |
null |
| Injection Safety | 0.771593 |
| Provide Infection Prevention | 0.664368 |
| Laboratory Network | 0.522662 |
| Healthcare-associated Infections | 0.514349 |
| Antimicrobial Resistance Regional | 0.670839 |
| HAI Detection | 0.620645 |
| email address | 0.629042 |
| CDI | 0.428859 |
| Control Assistance | 0.508776 |
| navigation Skip | 0.649962 |
| recent work | 0.630475 |
| Clostridium difficile infection | 0.688757 |
| Appropriate Antibiotic | 0.536346 |
|
| Educational Efforts | 0.524797 |
| list Skip | 0.651889 |
| monthly update | 0.642833 |
| page options Skip | 0.767254 |
| Coordinated Prevention | 0.544769 |
| Infection Control Assessment | 0.669574 |
| ELC HAI-funded Activities | 0.651671 |
| Health Department Capacity | 0.613914 |
| Antimicrobial Resistance | 0.682041 |
| infectious disease | 0.645601 |
| Laboratory Capacity | 0.535087 |
| information | 0.419665 |
| HAI Prevention Infrastructure | 0.941271 |
|
CLICK HERE |
| 6928 |
Centers for Disease Control and Prevention |
Html |
en |
Air Quality Awareness Week - April 30-May 4, 2012 - Announcement |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.458161 |
| U.S. Government Printing | 0.556603 |
| original MMWR paper | 0.537704 |
| body mass | 0.43955 |
| long-term damage | 0.428962 |
| Human Services | 0.555592 |
| irritated throat | 0.436994 |
| assistive technology | 0.460166 |
| high levels | 0.445702 |
| U.S. Environmental Protection | 0.591631 |
| respiratory systems | 0.433899 |
| toxic pollutants | 0.463799 |
| automobile exhaust | 0.437863 |
| breathing difficulties | 0.433502 |
| average adult breathes | 0.569994 |
| U.S. Department | 0.553393 |
| MMWR HTML versions | 0.54147 |
| MMWR readers | 0.437675 |
| Broadcast air quality | 0.618794 |
| air pollution levels | 0.673128 |
| industrial emissions | 0.44117 |
| Air Quality Awareness | 0.816655 |
| electronic PDF version | 0.53122 |
| Awareness Week activities | 0.441581 |
|
| certain air pollutants | 0.627978 |
| U.S. residents | 0.575553 |
| Air Aware | 0.502368 |
| subject line | 0.457376 |
| Additional information | 0.440139 |
| small particles | 0.437353 |
| Contact GPO | 0.454785 |
| urban smog | 0.443874 |
| health concerns | 0.435512 |
| typeset documents | 0.432687 |
| trade names | 0.432072 |
| commercial sources | 0.431988 |
| asthma attack | 0.549355 |
| paper copy | 0.546625 |
| asthma sufferers | 0.683934 |
| Asthma Awareness | 0.667494 |
| current prices | 0.429624 |
| persons | 0.43149 |
| Long-term exposure | 0.430943 |
| extreme cases | 0.433112 |
| non-CDC sites | 0.430788 |
| original paper copy | 0.537001 |
| high enough levels | 0.440662 |
|
CLICK HERE |
| 7057 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Guinea-Bissau |
null |
| Content source | 0.892652 |
| HHS | 0.699811 |
| endorsement | 0.682673 |
| CDC | 0.617915 |
|
| non-federal site | 0.998525 |
| Notice | 0.617482 |
| sponsors | 0.49087 |
| information | 0.490002 |
|
CLICK HERE |
| 7663 |
Centers for Disease Control and Prevention |
Html |
en |
Off the Beaten Path: Violence, Women, and Art |
David J. Sencer CDC Museum |
| storytelling | 0.445367 |
| better understanding | 0.636715 |
| project | 0.475839 |
| girls | 0.476495 |
| hope | 0.43815 |
| issues | 0.477657 |
| executive director | 0.648156 |
| cutting-edge art | 0.672441 |
| themes | 0.437328 |
| basic human rights | 0.879973 |
| Yoko Ono | 0.720253 |
| awareness | 0.475565 |
| action | 0.44052 |
| nonprofit group Art | 0.856013 |
| Culture | 0.436962 |
| Beaten Path | 0.994825 |
| Randy Jayne Rosenberg | 0.895216 |
| important social messaging | 0.862091 |
| goal | 0.43886 |
| Japan | 0.442771 |
| important topic | 0.633104 |
| feeling | 0.451033 |
| countries | 0.442893 |
| Individual | 0.437232 |
| various definitions | 0.630715 |
|
| actions | 0.437668 |
| Hank Willis Thomas | 0.907078 |
| Wangechi Mutu | 0.665496 |
| women | 0.476572 |
| abuse | 0.437851 |
| contemporary artists | 0.667916 |
| inspiration | 0.442344 |
| world | 0.441913 |
| new conversation | 0.645776 |
| Art Works | 0.845575 |
| audiences | 0.44218 |
| France | 0.442628 |
| violence | 0.797955 |
| exhibition | 0.43803 |
| USA | 0.44224 |
| address systems | 0.653492 |
| positive social change | 0.862909 |
| Kenya | 0.448942 |
| beliefs | 0.437531 |
| secure life | 0.660021 |
| Palestine | 0.455024 |
| Family | 0.437136 |
| Mona Hatoum | 0.68242 |
| Community | 0.437039 |
|
CLICK HERE |
| 9110 |
Centers for Disease Control and Prevention |
Html |
en |
Exchange Transfusion - Malaria |
Malaria is a mosquito-borne disease caused by a parasite. CDC provides scientific leadership in fighting malaria at home and around the globe. |
| severe malaria | 0.953733 |
| CDC | 0.369135 |
| fact | 0.315352 |
| intravenous quinidine | 0.388233 |
| evidence | 0.349888 |
| data | 0.314688 |
| United States | 0.384968 |
| portion | 0.3169 |
| antimalarials | 0.315514 |
| significant association | 0.377859 |
| respiratory distress syndrome | 0.595819 |
| renal compromise | 0.388435 |
| survival outcome | 0.382603 |
| antimalarial drugs | 0.400915 |
| Adverse events | 0.378162 |
| exchange transfusion | 0.481979 |
| infected cells | 0.390146 |
| comprehensive study | 0.378625 |
| published literature | 0.376539 |
|
| adjunct ET | 0.509269 |
| cerebral malaria | 0.465888 |
| adjunct treatment | 0.406439 |
| toxic byproducts | 0.392081 |
| hypotension | 0.319437 |
| ventricular fibrillation | 0.384234 |
| acute respiratory distress | 0.600148 |
| complications | 0.315577 |
| entirety | 0.319241 |
| high parasite loads | 0.454134 |
| patients | 0.330635 |
| countries | 0.315553 |
| procedure | 0.315485 |
| National Malaria Surveillance | 0.524225 |
| rationale | 0.318754 |
| efficacy | 0.317835 |
| ET | 0.787431 |
| infected patient | 0.392683 |
|
CLICK HERE |
| 10913 |
Centers for Disease Control and Prevention |
Html |
en |
Questions to Ask Your Doctor About Colorectal Cancer Screening |
Questions you should ask your doctor about colorectal (colon) cancer screening tests if you are age 50 or older or are at higher than normal risk. |
| benefits | 0.321636 |
| Task Force | 0.433724 |
| sigmoidoscopy | 0.336742 |
| U.S. Preventive Services | 0.547092 |
| colorectal polyps | 0.553966 |
| screening tests | 0.470446 |
| adults | 0.324333 |
| insurance provider | 0.412302 |
| colorectal cancer screening | 0.683974 |
| genetic syndromes | 0.415595 |
| increased risk | 0.432527 |
| colonoscopy | 0.330942 |
| Lynch syndrome | 0.412165 |
| hereditary non-polyposis colorectal | 0.623421 |
| colorectal cancer | 0.963346 |
|
| Medicare | 0.323952 |
| decision | 0.323279 |
| people | 0.36175 |
| inflammatory bowel disease | 0.510476 |
| doctor | 0.407154 |
| risks | 0.321823 |
| individual basis | 0.432031 |
| FAP | 0.334094 |
| screening test | 0.461926 |
| family history | 0.411034 |
| doctors | 0.321496 |
| screening methods | 0.473277 |
| insurance plan | 0.411852 |
| familial adenomatous polyposis | 0.520796 |
|
CLICK HERE |
| 11008 |
Centers for Disease Control and Prevention |
Html |
en |
Meningococcal | Surveillance | CDC |
Meningococcal disease is a reportable condition in all states, with cases immediately reported to state health departments. CDC closely tracks meningococcal disease through the National Notifiable Disease Surveillance System and Active Bacterial Core surveillance. |
| CDC | 0.309783 |
| jurisdiction health departments | 0.384498 |
| data | 0.315372 |
| Bacterial Core surveillance | 0.387614 |
| Page | 0.316709 |
| number | 0.308524 |
| children | 0.316847 |
| Gram-negative diplococci | 0.347597 |
| state health departments | 0.3868 |
| HIV status | 0.344181 |
| historic lows | 0.358694 |
| View meningococcal disease | 0.554147 |
| meningococcal surveillance. | 0.506836 |
| positive blood culture | 0.38178 |
| normally sterile body | 0.454493 |
| meningococcal disease | 0.951832 |
| serogroup | 0.364428 |
| late 1990s | 0.35221 |
| young adults | 0.349458 |
| adolescence | 0.310005 |
| Territorial Epidemiologists | 0.349908 |
| college attendance | 0.344466 |
| Tracking | 0.309209 |
| proportion | 0.310254 |
|
| United States | 0.441314 |
| age group | 0.348049 |
| absence | 0.308782 |
| total cases | 0.355886 |
| reportable condition | 0.352473 |
| recent Council | 0.345331 |
| case counts | 0.345399 |
| CSF | 0.326537 |
| health departments | 0.446761 |
| polymerase chain reaction | 0.386176 |
| meningococcal disease surveillance | 0.55956 |
| cases | 0.361411 |
| Serogroups | 0.308024 |
| Notifiable Diseases Surveillance | 0.390251 |
| meningococcal conjugate vaccines | 0.558199 |
| case classification | 0.344934 |
| highest rates | 0.350526 |
| implement control measures | 0.398277 |
| sterile body site | 0.449861 |
| vaccination history | 0.345771 |
| isolates | 0.311179 |
| meningitidis-specific nucleic acid | 0.38434 |
| incidence | 0.316605 |
| Clinical purpura fulminans | 0.385717 |
|
CLICK HERE |
| 11690 |
Centers for Disease Control and Prevention |
Html |
en |
CDC update on first Ebola case diagnosed in the United States: 10-03-2014 | Media Advisory | CDC Online Newsroom | CDC |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| Dallas County | 0.640364 |
| CDC director | 0.786154 |
| Non-Media | 0.484067 |
| MPH | 0.456824 |
| United States | 0.647889 |
| telebriefing | 0.474799 |
| Beth P. Bell | 0.851305 |
| outbreak responders | 0.706678 |
| historical purposes | 0.672393 |
| State Health Services | 0.835815 |
| navigation Skip | 0.859896 |
| Ebola case | 0.704655 |
| transcript | 0.553233 |
| Friday | 0.441362 |
| U.S. DEPARTMENT | 0.618378 |
| MD | 0.43982 |
| PASSCODE | 0.478187 |
| Zoonotic Infectious Diseases | 0.874319 |
| Important Instructions | 0.639577 |
| dial | 0.444816 |
| National Center | 0.644468 |
| website | 0.444591 |
|
| M.D | 0.437426 |
| list Skip | 0.864733 |
| CDC Media | 0.734787 |
| question | 0.523798 |
| page options Skip | 0.991142 |
| Commissioner | 0.44879 |
| touchtone phone | 0.652432 |
| p.m. | 0.439002 |
| Texas Department | 0.634524 |
| Ebola Virus | 0.678371 |
| West Africa | 0.669605 |
| investigation | 0.44026 |
| HUMAN SERVICES | 0.617844 |
| visit | 0.439696 |
| time | 0.438024 |
| 15 minutes | 0.43651 |
| press conference | 0.62509 |
| Audio | 0.442757 |
| media briefing | 0.71444 |
| David Lakey | 0.688557 |
| INTERNATIONAL | 0.439987 |
|
CLICK HERE |
| 12378 |
Centers for Disease Control and Prevention |
Image |
null |
Breast Cancer: Know the Risks (600W x 2182H) |
null |
|
|
CLICK HERE |
| 13429 |
Centers for Disease Control and Prevention |
Html |
en |
Use of Aspirin for Prevention of Recurrent AtheroscleroticCardiovascular Disease Among Adults - 20 States and the District ofColumbia, 2013 |
Jing Fang, MD1; Mary G. George, MD1; Yuling Hong, MD, PhD1; Fleetwood Loustalot, PhD1 (Author affiliations at end of text). |
| annual telephone survey | 0.573014 |
| fatal coronary events | 0.587123 |
| myocardial infarction | 0.584564 |
| National Health Interview | 0.577235 |
| Associated Risk Factors | 0.57189 |
| Public health practitioners | 0.573907 |
| optional BRFSS modules | 0.575419 |
| cardiovascular disease event | 0.585497 |
| data collection methods | 0.585132 |
| health care providers | 0.575125 |
| secondary prevention | 0.582521 |
| health care services | 0.575267 |
| ASCVD risk factors | 0.688772 |
| hemorrhagic stroke accounts | 0.59184 |
| BRFSS cardiovascular health | 0.593758 |
| ischemic vascular disease | 0.596618 |
| sociodemographic characteristics | 0.587699 |
| different risk groups | 0.574014 |
| regular aspirin therapy | 0.798941 |
| Behavioral Risk Factor | 0.581202 |
| current guidelines | 0.573845 |
| heart attack | 0.813753 |
| median state response | 0.574291 |
| ASCVD risk status | 0.604103 |
|
| atherosclerotic cardiovascular disease | 0.659529 |
| eligible respondents | 0.604806 |
| State Public Health | 0.583994 |
| secondary ASCVD prevention | 0.706398 |
| states | 0.607439 |
| acute coronary syndrome | 0.585298 |
| ASCVD risk factor | 0.595999 |
| heart attack prevention | 0.656305 |
| risk factors management | 0.572083 |
| cardiovascular health module | 0.707928 |
| pain relief | 0.615364 |
| ischemic stroke | 0.603925 |
| cardiovascular disease | 0.705769 |
| Million Hearts initiative | 0.609187 |
| antiplatelet medications | 0.592662 |
| Promote School Health | 0.577212 |
| regular aspirin | 0.980409 |
| stroke | 0.668975 |
| Chronic Disease Prevention | 0.624592 |
| Mary G. George | 0.577922 |
| cardiovascular disease events | 0.5898 |
| coronary heart disease | 0.731429 |
| stroke prevention | 0.657322 |
| cardiovascular disease prevention | 0.609005 |
|
CLICK HERE |